title: Thrombosis of angioaccess in haemodialysed patients treated with human recombinant erythropoietin.
authors.forename: B
authors.initials: B
authors.lastname: Viron
authors.forename: F
authors.initials: F
authors.lastname: Chamma
authors.forename: B
authors.initials: B
authors.lastname: Jaar
authors.forename: C
authors.initials: C
authors.lastname: Michel
authors.forename: F
authors.initials: F
authors.lastname: Mignon
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001166:Arteriovenous Shunt, Surgical / Q000009:adverse effects; D004921:Erythropoietin / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011138:Polytetrafluoroethylene; D011994:Recombinant Proteins; D006435:Renal Dialysis / Q000009:adverse effects*; D012189:Retrospective Studies; D013927:Thrombosis / Q000209:etiology*
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin; D011138:Polytetrafluoroethylene